Ahmad, Saleem,Batt, Douglas G,Liu, Qingjie,Macor, John E.,Tino, Joseph A.,Watterson, Scott Hunter,Nair, Satheesh Kesavan,Maishal, Tarun Kumar
申请号：
HRP20192197
公开号：
HRP20192197T8
申请日:
2019.12.06
申请国别(地区):
HR
年份:
2020
代理人:
摘要：
or a salt thereof, wherein Q, R1a, R1b, R2a, R2b, R3, R4, R5a, R5b, R6a, R6c, R7a, R7b, R7c, and R7d are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
